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Abstract The most common human microdeletion occurs
at chromosome 22q11.2. The associated syndrome
(22q11.2DS) has a complex and variable phenotype with
a high risk of schizophrenia. While the role of stress in the
etiopathology of schizophrenia has been under investigation
for over 30 years (Walker et al. 2008), the stress–diathesis
model has yet to be investigated in children with
22q11.2DS. Children with 22q11.2DS face serious medical,
behavioral, and socioemotional challenges from infancy
into adulthood. Chronic stress elevates glucocorticoids,
decreases immunocompetence, negatively impacts brain
development and function, and is associated with psychi-
atric illness in adulthood. Drawing knowledge from the
extant and well-developed anxiety and stress literature will
provide invaluable insight into the complex etiopathology
of schizophrenia in people with 22q11.2DS while suggest-
ing possible early interventions. Childhood anxiety is
treatable and stress coping skills can be developed thereby
improving quality of life in the short-term and potentially
mitigating the risk of developing psychosis.
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Introduction
Chromosome 22q11.2 deletion syndrome (22q11.2DS)
results from a one point 5 to three-megabase deletion on
the q11 band of chromosome 22 (Driscoll et al. 1993;
Scambler 2000; Botto et al. 2003). Alongside physical,
cognitive, and socioemotional impairments, 22q11.2DS
confers a 25- to 30-fold increased risk for schizophrenia
over the general population. Only the rare occurrence of
having two parents or a monozygotic twin with schizo-
phrenia confers a greater risk. In patients with a diagnosis
of schizophrenia, there is a 20- to 80-fold elevated
prevalence of the deletion compared to the general
population (Murphy 2002; Bassett et al. 2003). There are
no clear clinical phenotypic differences between schizo-
phrenic patients with and without 22q11.2DS (Bassett et al.
2003;A r i n a m i2006). Early identification makes
22q11.2DS an ideal research population for prospectively
investigating risk and protective factors for schizophrenia.
Recently, Karayiorgou and colleagues (2010) highlight-
ed the complexity of the pathogenesis and pathophysiology
of 22q11.2DS, especially as it relates to predicting
psychosis and further indicating the need for longitudinal
studies. The single prospective study of children with
22q11.2DS (Gothelf et al. 2007) found that baseline anxiety
and mood, lower verbal IQ, and psychotic symptoms, along
with catechol-O-methyltransferase (COMT) genotype, pre-
dicted young adult onset and severity of psychosis.
Somewhat surprisingly, given the richly developed human
and animal literature on the effects of anxiety and stress on
brain development and risk of neuropsychiatric disease
(Bremner et al. 1997; Heim and Nemeroff 2001; McEwen
2003; Marco et al. 2010) and schizophrenia in particular
(Read et al. 2005; Morgan and Fisher 2007; Walker et al.
2008; Freeman and Fowler 2009), there has been no
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sequelae of stress in this population.
Children with 22q11.2DS have real and ongoing
physiological and psychological stressors beyond those of
typically developing children. Anxiety is common in
children with 22q11.2DS and likely results from a
multivariate interaction of genetically derived temperament
(Swillen et al. 1999; Jabbi et al. 2007; Michaelovsky et al.
2008), early traumatic experiences (e.g., cardiac surgery;
Mahle et al. 2003), and the day-to-day challenges (medical
and otherwise) associated with the syndrome. Anxiety is a
cognitive manifestation of fear and can elicit a robust
sympathetic stress response (de Catanzaro 1999) that can
deplete physiological coping resources and exacerbate
existing cognitive and socioemotional impairments in a
reciprocal fashion.
Genetic copy number and genotypic variations in the
deleted region evidently contribute to the etiopathogenesis of
schizophrenia and also predict susceptibility to stress and
anxiety in populations without 22q11.2DS (Stein et al. 2005;
Roussos et al. 2009). Furthermore, chronically elevated
glucocorticoid release as part of the stress response can
negatively affect brain development in humans and animal
models (McEwen 2007). Therefore, we suggest that several
aspects of 22q11.2DS may both contribute to and be
exacerbated by the pathological sequelae of coping with
long-term, and often unpredictable, stressors. This is not a
simple unidirectional relationship. The physiological effects
of chronic stress in children with 22q11.2DS may trigger the,
as yet, undefined diathesis leading to schizophrenia. How-
ever, we do not claim that anxiety or stress causes
schizophrenia in children with 22q11.2DS. There are many
groups of people with developmental disabilities coping with
serious stressors related to those disabilities that do not
possess the same risk of developing schizophrenia as
children with 22q11.2DS. Conversely, there are populations
with intellectual and developmental disabilities such as
multiple complex developmental disorder at risk for psycho-
sis (Sprong et al. 2008) but again, not to the same degree as
children with 22q11.2DS.
The microdeletion imparts a developmental risk that has
not yet been clearly elucidated and is neither necessary nor
sufficient for developing schizophrenia. The evidence that
approximately 2% of patients with schizophrenia were
found to have a chromosome 22q11.2 deletion (Bassett and
Chow 1999) and that approximately two thirds of children
with the deletion will not develop schizophrenia highlights
the need for further research elucidating not just risk factors
but also factors that protect against psychopathology (Baker
and Skuse 2005; Stoddard et al. 2010).
We suggest that a high preponderance of serious
negative life events throughout development in combina-
tion with greater susceptibility to stress and anxiety, and
poorer coping skills contribute to risk of schizophrenia in
people with 22q11.2DS. Below, we review relevant data
and suggest how the anxiety and stress literature can
increase our understanding of the risk factors that lead to
schizophrenia in one third of children with 22q11.2DS.
Stressors associated with 22q11.2DS
Traumatic early life experiences can shape the physiolog-
ical stress response over development and are predictive of
atypical hypothalamic–pituitary–adrenal (HPA) axis activa-
tion and neuroendocrine dysregulation (Plotsky and
Meaney 1993; Heim and Nemeroff 2001; Turner-Cobb
2005; Elzinga et al. 2008) and psychosis (Freeman and
Fowler 2009) in adulthood. From an early age, children
with 22q11.2DS often have extensive and serious medical
issues. Pathophysiological manifestations of the deletion
can include a variety of cardiac and palatal anomalies,
immunological deficiencies, and metabolic and endocrine
disorders (Bassett et al. 2005; Shprintzen 2008). Congenital
cardiac defects can impact myocardial and cerebral devel-
opment (Carotti et al. 2008; Rudolph 2010), and serious
variants, including tetralogy of Fallot, require very compli-
cated, early surgical intervention. These occur in 49–83%
of cases (Kobrynski and Sullivan 2007). Childhood
bacterial and viral infections are common in 22q11.2DS,
especially in those with defective or even absent thymus
resulting in immunodeficiency and disordered T cell
development (McLean-Tooke et al. 2007). In infancy,
breastfeeding can be impacted with poor suckling and
nasal regurgitation owing to malformations of the palate
resulting in feeding complications that can extend into
childhood (Cooper-Brown et al. 2008).
The cognitive profile of children with 22q11.2DS has
been characterized as uneven with a mean full scale IQ
between 70 and 85 (Woodin et al. 2001). Delays and
impairments in language comprehension and production,
visuospatial and numerical processing (Bearden et al. 2001;
Simon et al. 2005a), attention, and executive function
(Dufour et al. 2008) are typical in this population. As the
child with 22q11.2DS ages and enters the school system,
his or her cognitive and social impairments become
more apparent in the context of increasing social and
academic expectations. In the socioemotional arena, chil-
dren with 22q11.2DS often have social and communication
impairments and are more likely to be anxious, shy, and
socially withdrawn (Swillen et al. 2001). They are more
likely to be diagnosed with mood disorders, attention
deficit hyperactivity disorder (ADHD), and obsessive–
compulsive disorder (OCD) (Arnold et al. 2001), all of
which further impact their ability to perform well in school
and develop positive reciprocal relationships with peers
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learning difficulties (Burkhardt 2005), and this often
induces potent sympathetic nervous responses that may
contribute to dysregulation of the HPA axis in those
children who are bullied (Vaillancourt et al. 2008).
Parental coping ability and access to socioemotional and
financial support is also a critical component of a child’s
ecology and can serve as protective factors or further
contribute to stress and anxiety. Parents of children with
22q11.2DS face numerous challenges, including medical
care and costs, educational difficulties, and general uncer-
tainty about the future. Parents vary in their coping abilities
based on social and financial support. Parents report feeling
anxious in response to behavior problems in their infants
with 22q11.2DS (Briegel et al. 2007). They also worry that
older children will develop a psychotic illness (Hercher and
Bruenner 2008). Parental anxiety can increase children’s
stress levels and positively correlates with increased illness
in typical children (Wyman et al. 2007; Caserta et al. 2008)
likely owing to stress-induced suppression of the immune
response (Webster Marketon and Glaser 2008).
Stress, allostatic load, and the HPA axis
Allostatic load is the physiological cost of maintaining
homeostasis when faced with severe or chronic stress.
Allostasis can occur via physiological (e.g., cortisol release
or blood pressure elevation) or behavioral (e.g., avoiding
stress-inducing stimuli) mechanisms that are elicited in
response to real or perceived challenges. While modulated
by individual differences in genotype, experience, and
environment, allostatic load can increase over time to the
point of overload and exhaustion. Allostatic overload
exhausts coping resources and overexposes the organism to
the hormonal, immunological, and neural mediators released
via chronic activation and dysregulation of the HPA axis.
Allostatic overload can also manifest as an inability to
habituate to stressors, a failure to inhibit the stress response
when not needed or as the lack of an effective stress response
when one is truly needed (McEwen 2007).
The HPA axis is a neural and glandular system that
mediates physiological and behavioral responses to stres-
sors, including the release of glucocorticoids (GC). The
HPA axis is the most intensely investigated “stress
response” system and is known to play a critical role in
effectively coping with threat. In response to physical or
psychological stressors, corticotrophin releasing hormone is
secreted from the anterior part of the periventricular nucleus
of the hypothalamus, which in turn stimulates adrenocorti-
cotrophin releasing hormone (ACTH) from the anterior
pituitary. This stimulates the release of androgenic steroids,
mineralocorticoids, and GCs from the cortices of the
adrenal glands. Cortisol is the GC found in primates and
GC and mineralocorticoid receptors are found throughout
the periphery and brain. Cortisol release is regulated by
ACTH via episodic release in a circadian rhythm and by
negative feedback of cortisol on ACTH (Sapolsky 2003;
Aron et al. 2004). Released as part of the stress response,
cortisol liberates energy stores, increases cardiac output,
and elevates mood and appetite while suppressing anabolic
functions not immediately necessary to survival. However,
chronic and unpredictable stressors can produce prolonged
HPA axis activation with persistent elevated GC release
(Sapolsky et al. 1986; Johnson et al. 1992). Chronic GC
elevation is associated with pathologies, including depres-
sion and anxiety, immunological impairments, and nervous
system damage, particularly involving the hippocampus in
animals and humans (Sapolsky et al. 1990; Lange and Irle
2004;Y a n ge ta l .2008). Chronic GC activation also
increases prefrontal lobe vulnerability to inflammation (de
Pablos et al. 2006), and higher baseline cortisol levels have
been reported in patients with schizophrenia with a
commensurate increase in negative symptoms during
withdrawal from antipsychotic medications (Walker et al.
2008). Gene expression associated with upregulation of
inflammatory processes have been found in the post-
mortem brains of patients with schizophrenia (Saetre et al.
2007), suggesting a possible feed-forward mechanism that
may contribute to atypical frontal lobe function reported in
patients with schizophrenia (Weinberger et al. 2001) while
possibly increasing stress sensitivity via a reduction in
frontal modulation of limbic activity.
Stress and brain morphology
The correlation between genotype and phenotype can be
low in 22q11.2DS, with even monozygotic twins demon-
strating significant variability in symptom presentation
(Goodship et al. 1995; Yamagishi et al. 1998; Hillebrand
et al. 2000). However, similarities in brain morphometry
exist between persons with 22q11.2DS and schizophrenia
patients without 22q11.2DS (van Amelsvoort et al. 2001;
Simon et al. 2005b; Kates et al. 2006). These neural
anomalies are driven by both genetic and epigenetic factors
and perhaps also in response to allostatic load. For
example, children and adults with 22q11.2DS show
hippocampal volume reductions (Debbané et al. 2006;
DeBoer et al. 2007) similar to individuals with schizophre-
nia (Velakoulis and Pantelis 1996). Decreased dendritic
arborization in the hippocampus may be accounted for by
dysregulation of neural and synaptic genes as demonstrated
in mouse models (Karayiorgou et al. 2010). However,
chronic GC exposure is also associated with neuronal
death, increased cytotoxic susceptibility to metabolic
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plexity and spine density in the hippocampi of animals
(Sapolsky 1985, 1986; Sapolsky et al. 1985; Woolley et al.
1990; Mizoguchi et al. 1992; Margariños et al. 1996;
McEwen 1999), and memory impairments and hippocam-
pal atrophy in aged humans. It is possible that the lower
hippocampal volumes reported in people with 22q11.2DS
(e.g., Debbané et al. 2006; DeBoer et al. 2007) may not
only reflect an atypical maturational process but also an
atrophying process with functional implications as hippo-
campal volume is correlated with verbal IQ (Toulopooulou
et al. 2004). In children with 22q11.2DS, a decline in verbal
IQ along with COMT haplotype, elevated anxiety, and
negative mood was predictive of psychotic symptom
severity in young adulthood (Gothelf et al. 2005, 2007).
Overall brain volume is 8–11% smaller in children with
22q11.2DS than typically developing children and appears in
an anterior to posterior pattern (Eliez et al. 2000; Kates et al.
2001; Simon et al. 2005b), which suggests a possible
mechanism for emotional dysregulation in children with
22q11.2DS given the modulatory role of the frontal cortices
on limbic activity and reactivity (Kinsbourne 1978; Fox et al.
1996;D a v i d s o n2002). Abnormalities in frontal and limbic
connectivity was recently demonstrated by Sigurdsson and
colleagues (2010)w i t haDf(16)A
+/− mouse model of the
human chromosome 22q11.2 deletion. These mice possess
baseline dorsal hippocampal and medial prefrontal asynchrony
associated with learning impai r m e n t so naw o r k i n gm e m o r y
task. These findings mirror spatial working memory impair-
ments reported in people with 22q11.2DS (Kates et al. 2007).
Here too, GC activity may contribute to these observations.
Stress and corticosterone (Diamond and Rose 1994; Alfarez et
al. 2003) suppress long-term potentiation in Cornu ammonis 1
of the dorsal hippocampus and in the medial prefrontal cortex
(mPFC; Maroun and Richter-Levin 2003) possibly contribut-
ing to abnormal connectivity between these regions.
Genotype and susceptibility to stress
The role of dopamine (DA) dysregulation in schizophrenia
focused research on COMT haplogenotype in relation to
psychopathology in 22q11.2DS (e.g., Dunham et al. 1992;
Bassett et al. 2007; Gothelf et al. 2008) hypothesizing a
modulation of schizophrenia susceptibility in individuals
with and without 22q11.2DS (Arinami 2006; Bassett et al.
2007; Williams et al. 2007). Since 22q11.2DS results from
a hemizygous deletion, probable reductions in messenger
RNA and proteins produced by the potentially polymor-
phous genes in the unaffected chromosome may contribute
to psychosis risk (Michaelovsky et al. 2008). COMT is an
enzyme that inactivates catecholamines such as norepi-
nephrine and dopamine. Lower enzymatic action on DA
may increase the likelihood of psychosis due to an
overabundance of synaptic DA (Carlsson 1988; Dunham
et al. 1992) and the low-activity allele has been correlated
with ADHD, OCD, and schizophrenia incidence in some
studies of 22q11.2DS (Bassett et al. 2007; Gothelf et al.
2007; Michaelovsky et al. 2008) and the general population
(Shifman et al. 2002) but not in others (Murphy et al. 1999;
Fan et al. 2005; Murphy and Scambler 2005) likely because
of additional genetic and experiential variation (Craddock
et al. 2006; Michaelovsky et al. 2008). Furthermore, while
DA activity is enhanced by GCs in the prefrontal cortex
(Mizoguchi et al. 2004), understanding of the complex
relationship between CG and DA is still developing
(Craenenbroeck et al. 2005).
Consider also that COMT appears to contribute to
individual variability in stress sensitivity and coping. The
COMT variant interacts with polymorphic variants of genes
coding for monoamine oxidase A and serotonin transporters
that increase susceptibility to major depression and anxiety
via differences in ACTH secretion and HPA reactivity
(Jabbi et al. 2007). When compared to carriers with the
high-activity COMT allele, healthy adult carriers of the
low-activity COMT allele show greater prefrontal cortical,
amygdalar, and hippocampal activation in response to
emotional tasks such as viewing faces displaying negative
emotion (Smolka et al. 2005; Drabant et al. 2006). The low-
activity COMT variant has also been linked to greater stress
sensitivity, negative affect, and psychosis in response to an
emotional task (van Winkel et al. 2008).
Recently, Gothelf and colleagues (2010)r e p o r t e dt h a ta g e -
related reductions in left dorsal prefrontal cortical (dPFC)
gray matter volume predicted psychosis in adolescents and
young adults with 22q11.2DS. Furthermore, those individu-
als with 22q11.2DS that possessed the low-activity COMT
allele had greater reductions in dPFC than did those with the
high-activity COMT allele. Other differences included
decreased dorsal cingulum but increased volume of the
mPFC, orbitofrontal cortex, and right amygdala. There is
ample evidence that even relatively mild acute stress impairs
PFC function and that protracted, intense, or uncontrollable
stress reduces dendritic length, arbor complexity, and spine
density in PFC and this may be moderated by COMT variant
(see Arnsten 2009 for a review). Changes in prefrontal and
limbic regions related to anxiety and negative life events
have been reported in other populations of children both
with and without neurodevelopmental disorders. For exam-
ple, greater right amygdala volume is predictive of anxiety in
children with autism (Juranek et al. 2006). In another
example, larger amygdala volumes in healthy children are
associated with length of time spent in less-than-optimal
rearing conditions such as an orphanage (Tottenham et al.
2010). Richert and colleagues (2006) found that children
with post-traumatic stress disorder (PTSD) had lower total
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and ventral PFC volumes when compared to children without
PTSD. The authors suggest that this may indicate atypical
brain development resulting in a premorbid risk factor that
potentiates emotional dysregulation and fear or that changes
in these regions reflect “use-dependent” prolonged activation
of corticolimbic circuits following trauma. These are not
mutually exclusive hypotheses and neither is the COMT
genotype reported in Richert and colleagues’ (2006)s t u d yo f
PTSD in children. However, these examples highlight the
need for further investigation in order to better understand
the relationships between such processes given that at least
one commonality between children with PTSD that are
otherwise healthy and many children with 22q11.2DS is
some experience of chronic stress.
COMT is not the only gene in the deleted region
associated with stress reactivity and anxiety in popula-
tions without 22q11.2DS. The proline dehydrogenase
(PRODH) gene in the 22q11.2 deleted region, regulates
glutamate and γ- a m i n o b u t y r i ca c i da l s om a k i n gi ta
critical candidate in the etiopathology of schizophrenia in
this population (Liu et al. 2002). In healthy adults,
PRODH variant is associated with elevated prepulse
inhibition, schizotypy, and greater anxiety (Roussos et al.
2009). Thus, in 22q11.2DS, PRODH haplotype might
further contribute to stress sensitivity and anxiety via its
actions on glutamate (Mathew et al. 2008).
Summary and future directions
Thewell-establishedbodyofanxietyandstressresearchhasyet
to be utilized to further clarify psychosis risk in 22q11.2DS,
whose childhood population is, arguably, a near perfect model
of early traumatic experience and chronic stress leading to an
uncertain adulthood. These children have significant physical,
cognitive, and socioemotional impairments they must over-
come on a daily basis. We restate that we do not posit that stress
or allostatic load causes schizophrenia in people with
22q11.2DS. Rather, that chronic stress and anxiety with
associated physiological sequelae may modulate risk of
psychosis. This is not a simplistic cause and effect relationship
but rather a series of negative hits to an already challenged
developing system. Susceptibility to stress may be modulated
by allelic variation and phenotypic variability that may include
serious medical issues such as major cardiac malformations
early in development. Furthermore, variability in parental and
community resources contribute to the complexity of under-
standing risk and resilience in these children.
To truly test the hypothesis that chronic and repeated
stressors contribute to the risk of schizophrenia in people
with 22q11.2DS will require longitudinal study from
earliest diagnosis to adulthood. However, important longi-
tudinal inferences may be drawn from cross-sectional
analyses and provide insight into the 22q11.2DS endophe-
notype at risk for schizophrenia. Furthermore, anxiety
disorders in children are amenable to treatment, and stress
coping skills can be developed (e.g., Kendall 1994). It
should be possible to tailor interventions for children with
22q11.2DS that will have an impact not only on quality of
life in the short-term, but also mitigate proposed stress-
related risk of schizophrenia.
A detailed survey of all of the established methodologies
for measuring stress and its physiological and developmen-
tal sequelae is beyond the scope of this article. There is
evidently a great deal of work still to be done in order to
tease apart the factors that affect psychiatric outcomes in
22q11.2DS. However, we suggest that a relatively simple
first step would be to characterize stress reactivity in people
with 22q11.2DS by measuring cortisol release at rest and in
response to a mild stressor in relation to standardized
measures of anxiety, mood, and life events. As of this
writing, there are no published reports characterizing
cortisol at rest or in reaction to any form of stressor in
people with 22q11.2DS. As noted previously, cortisol
modulates a wide variety of metabolic processes but in
the context of a physical or emotional challenge, it is often
thought of as a “stress” hormone as HPA-regulated
sympathetic nervous system activation elevates cortisol
levels. Other metabolic factors can be measured with
cortisol such as dehydroepiandrosterone (DHEA). DHEA
is an ACTH-regulated steroid that possesses anti-
glucocorticoid properties (Kalimi et al. 1994) and the ratio
of cortisol to DHEA may be a more nuanced metric of HPA
axis tone, physical and psychological stress, resistance, and
coping in children (Goodyer et al. 1998). These hormonal
measures could also be accompanied by simple psycho-
physiological indicators of sympathetic nervous system
activation such as galvanic skin response, heart rate, and
blood pressure (see Schmidt and Segalowitz 2007 for a
review) and these metrics could be tested against a variety
of variables including COMT haplotype (van Winkel et al.
2008) and/or brain function (Bremner 2007) and structure
(Sowell et al. 2004; Spinelli et al. 2009).
In summary, chronic stress and its sequelae may play a
critical but as yet, uninvestigated bidirectional role in the
physical, cognitive, and socioemotional development of
children with 22q11.2DS and the likelihood of psychosis in
adulthood.
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